Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation

Introduction

April 2012

Welcome to Mayo Medical Laboratories' Hot Topics. These presentations provide short discussions of current topics and may be helpful to you in your practice.

Our presenter for this program is Andrew McKeon, MB BCh (N-AI), consultant in the Neuroimmunology Laboratory in the Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota. Dr. McKeon will review the diagnostic testing algorithm for autoimmune gastrointestinal dysmotility (AGID), define the clinical utility of an Autoimmune Gastrointestinal Dysmotility Evaluation, and describe interpretation of laboratory testing. Thank you, Dr. McKeon.

Thank you, Sharon, for that introduction. Hello, my name is Dr. Andrew McKeon. I am going to talk to you today about a new evaluation to aid the evaluation of patients with a suspected autoimmune gastrointestinal dysmotility disorder.

Introduction

Next Slide >

 

Jump to section:

• New Profile
• AGID
• Symptoms
• AGID¹
• AGID^1,2
• AGID: Laboratory Findings
• AGID: Antibody Evaluation
• Ganglionic Acetylcholine Receptor (AChR) Autoantibody^3,4
• Ganglionic AChR Autoantibody
• AGID Antibody Profile
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• AGIDE/89886 Algorithm
• Clinical Utility of AGID Evaluation
• Clinical Utility of AGID Evaluation
• Summary
• References
• Questions